Semaglutide Cycle Guide

What Is Semaglutide and Why Does Dosing Matter?

Semaglutide (Semaglutide (GLP-1 receptor agonist)) is a GLP-1 receptor agonist incretin mimetic. Synthetic GLP-1 analog developed by Novo Nordisk with amino acid modifications for extended half-life. Getting the dosage right is critical — too little may produce no measurable effect, while excessive amounts increase risk without proportional benefit.

The standard research dosage for Semaglutide has been established through preclinical studies and community protocols. This guide covers the evidence-backed dosing range, timing, and cycle structure.

What Is the Recommended Semaglutide Dosage?

The most widely used Semaglutide dosage is 0.25-2.4 mg weekly (injection) or 3-14 mg daily (oral), administered once weekly (injection) or daily (oral) via subcutaneous injection or oral.

Beginners should start at the lower end of this range and titrate upward only if needed. The half-life of Semaglutide is 7 days, which directly determines how often you need to dose to maintain stable blood levels.

For Semaglutide specifically, the ongoing, titrated over 4-5 weeks cycle length is standard. Longer isn't always better — GLP-1 receptor agonist incretin mimetic compounds require cycling to maintain receptor sensitivity.

When Should You Dose Semaglutide?

With a half-life of 7 days, timing your Semaglutide administration affects peak blood levels. Most protocols call for once weekly (injection) or daily (oral).

For peptides administered before bed (common with GH-related compounds), the goal is to amplify the natural nocturnal growth hormone pulse. For healing peptides, proximity to the injury site via local injection can improve outcomes.

How Do You Reconstitute Semaglutide?

Semaglutide typically comes as a lyophilized (freeze-dried) powder. Reconstitute with bacteriostatic water — never saline or sterile water, as BAC water contains 0.9% benzyl alcohol that prevents bacterial growth and extends shelf life to 4-6 weeks.

Use our peptide dosing calculator to determine the exact amount of BAC water to add based on your vial size and desired dose per injection.

How Long Should a Semaglutide Cycle Last?

Standard Semaglutide cycles run ongoing, titrated over 4-5 weeks. This timeframe is based on the compound's mechanism and the time needed to observe measurable effects.

STEP trials: 16-22.5% weight loss at 2.4 mg vs 3.1% placebo at 68 weeks. Multiple cardiovascular outcome trials. Approved for diabetes (2017), weight management (2021), and kidney disease (2025). 15,000+ clinical trial subjects.

What Side Effects Can Affect Dosing?

Nausea, vomiting, diarrhea (20-40% incidence, decreasing over 4-8 weeks). Thyroid C-cell tumor risk in rodents (human relevance unclear). Rare pancreatitis and diabetic retinopathy worsening.

If side effects emerge, the first step is typically reducing the dose rather than discontinuing entirely. Most Semaglutide-related side effects are dose-dependent.

How Does Semaglutide Dosing Change When Stacking?

Dual pathway activation possible with GIP agonists (tirzepatide). Complements SGLT2 inhibitors for enhanced glycemic control.

When stacking, some researchers reduce individual peptide doses by 20-30% since synergistic effects mean full doses of each aren't always necessary.

What Is the Bottom Line on Semaglutide Dosing?

Start at 0.25, dose once weekly (injection) or daily (oral), and run cycles of ongoing, titrated over 4-5 weeks. Monitor your response and adjust within the established range.

Source matters — always use research-grade Semaglutide from vendors with third-party COA testing. Underdosed or contaminated products are the most common reason for poor results.

Related Reading

• Semaglutide Benefits
• Semaglutide Side Effects
• Semaglutide Stacking Guide
• Semaglutide Cycle Guide
• Semaglutide Research
• ARA-290 Complete Guide

Frequently Asked Questions